|
This article is taken from the Spring 2008 issue of LymphLine, the LSN's quarterly newsletter available to all LSN members.
For details of how to become a member, click here. LSN wins Impact award!
The LSN has been short-listed from 440 organisations to the final 10 to receive a GlaxoSmithKline Impact Award of £25,000 The GlaxoSmithKline Impact Awards are an annual scheme, funded by GlaxoSmithKline as part of the company's commitment to promote community health and well-being. The awards are now in their eleventh year, and recognise and reward small to medium sized charities that are doing excellent work to improve people's health. They are organised and managed in partnership with the King's Fund, a leading independent health charity working to improve health and social care. Criteria used to assess applications
The judges look for evidence of: Innovation
Management
Partnership
Achievement
Community Focus
Targeting Needs
All short-listed organisations are visited by an independent assessor. The assessors are managed by the King's Fund and have extensive experience in community health and organisational development. The LSN underwent an intensive four hour assessment in November and a report of this meeting was fed back to the judging panel. Final judging took place at the end of January and the LSN was subsequently contacted with the good news that the Charity had got through to the final ten. The next step is that the LSN will be contacted by a PR company with the view to producing a short video outlining the work of the Charity. This video will be shown at an 'Oscars' style award winners' ceremony to be held on 29 April at the National Gallery, when the 'overall' winner will be announced. Should the LSN be fortunate enough to win 'first prize', a further £10,000 will be presented to the Charity. Editor's note: Details of the award ceremony will be published in the next issue of LymphLine. |